A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy
Weixin Zhang, Jiao Huang, Xin-Yi Tian, Yunhe Liu, Mei-Qi Jia, Wang Wang, Cheng‐Yun Jin, Jian Song, Sai‐Yang Zhang, Sai‐Yang Zhang
Topics & Concepts
ChemistryVorinostatHistone deacetylaseAcetylationRational designPharmacologyHydroxamic acidHistoneCancer therapyCancer cellCancerCancer researchBiochemistryMedicineBiologyGeneStereochemistryInternal medicineGeneticsHistone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsPeptidase Inhibition and Analysis